IGF1 and osteosarcoma: By performing a serial analysis of a gene expression experiment comparing osteosarcomas with normal osteoblasts and mesenchymal stem cells, the authors identified the insulin-like growth factor (IGF) pathway and the transforming growth factor-β (TGF-β) pathway as possible targets for therapy.